Opium use and risk of colorectal cancer: a multi-center case-referent study in Iran

Authors

  • Maryam Hadji a Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland; b Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran
  • Maryam Marzban c Department of Public Health, School of Public Health, Bushehr University of Medical Science, Bushehr, Iran; d Clinical Research Development Center, The Persian Gulf Martyrs, Bushehr University of Medical Science, Bushehr, Iran
  • Hamideh Rashidian b Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran
  • Ahmad Naghibzadeh-Tahami e Modeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran; f Regional Knowledge HUB for HIV/AIDS Surveillance, Research Centre for Modelling in Health, Institute for Future Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
  • Mahin Gholipour g Metabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran
  • Elham Mohebbi b Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran
  • Roya Safari-Faramani h Research Center for Environmental Determinants of Health, School of Public Health, Kermanshah Medical Sciences University, Kermanshah, Iran
  • Monireh Sadat Seyyedsalehi b Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran
  • Bayan Hosseini b Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran; i International Agency for Research on Cancer, Lyon, France
  • Reza Alizadeh-Navaei j Gastrointestinal Cancer Research Center, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran
  • Abbas Rezaianzadeh k Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  • Abdolvahab Moradi g Metabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran
  • Soodabeh ShahidSales l Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  • Farid Najafi i International Agency for Research on Cancer, Lyon, France;m Research Center for Environmental Determinants of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran
  • Vahid Moazed n Endocrinology and Metabolism Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran
  • Ali Akbar Haghdoost f Regional Knowledge HUB for HIV/AIDS Surveillance, Research Centre for Modelling in Health, Institute for Future Studies in Health, Kerman University of Medical Sciences, Kerman, Iran; o HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
  • Afarin Rahimi-Movaghar p Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran
  • Arash Etemadi q Digestive Oncology Research Center, Digestive Diseases Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran; r Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
  • Reza Malekzadeh q Digestive Oncology Research Center, Digestive Diseases Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran; s Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  • Paolo Boffetta t Stony Brook Cancer Center, Stony Brook University, Stony Brook, NY, USA; u Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
  • Elisabete Weiderpass i International Agency for Research on Cancer, Lyon, France
  • Farin Kamangar v Department of Biology, School of Computer, Mathematical, and Natural Sciences, Morgan State University, Baltimore, MD, USA
  • Kazem Zendehdel b Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran; w Cancer Biology Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran

DOI:

https://doi.org/10.1080/0284186X.2023.2276326

Keywords:

IROPICAN, opium, colon cancer, rectum

Abstract

Background

Opium use has been associated with an increased risk of cancers of the lung, oesophagus, and pancreas, and it was recently classified by the International Agency for Cancer Research as carcinogenic to humans. It is not clear whether opium also increases the risk of colorectal cancer (CRC). The aim of our study was to assess the association between various metrics of opium use and the risk of CRC.

Methods

This case-referent study from seven provinces in Iran comprised 848 CRC cases and 3215 referents. Data on opium use (duration, amount, frequency) and potential confounders were collected by trained interviewers. Multivariable unconditional logistic regression models were used to measure odds ratios (OR) adjusted for age, gender, province, marital status, family history of CRC-linked cancers, consumption of red meat, fruits and vegetables, body shape, occupational physical activity, and socioeconomic status.

Results

Regular opium consumption was not associated with the risk of CRC (OR 0.9, 95% confidence interval, CI: 0.7, 1.2) compared to subjects who never used opium. However, frequent opium use more than twice a day was associated with an increased risk of CRC compared to non-users of opium (OR: 2.0, 95% CI: 1.1, 3.8; p for quadratic trend 0.008).

Conclusion

There seems to be no overall association between opium use and CRC, but the risk of CRC might be increased among persons who use opium many times a day.

Downloads

Download data is not yet available.

Downloads

Published

2023-12-02

How to Cite

Hadji, M., Marzban, M., Rashidian, H., Naghibzadeh-Tahami, A., Gholipour, M., Mohebbi, E., … Zendehdel, K. (2023). Opium use and risk of colorectal cancer: a multi-center case-referent study in Iran. Acta Oncologica, 62(12), 1661–1668. https://doi.org/10.1080/0284186X.2023.2276326